There were 2,447 press releases posted in the last 24 hours and 441,337 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Connect Biopharma to Announce Top-Line Data from the Global Phase 2b Trial of Rademikibart in Patients with Moderate-to-Severe Asthma on December 12, 2023

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image